Sales and Marketing

Showing 15 posts of 11527 posts found.

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020 Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …

Pfizer sues US for permission to help Medicare patients with rare heart conditions

June 29, 2020 Sales and Marketing Medicaid, Medicare, Pfizer

Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020 Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

NICE knocks back Novartis’ Mayzent in secondary progressive multiple sclerosis over data gaps

June 25, 2020 Sales and Marketing Mayzent, NHS, NICE, Novartis

Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment …

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020 Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …

Boehringer withdraws its £700m investment in Hikma Pharmaceuticals

June 23, 2020 Manufacturing and Production, Sales and Marketing Boehringer, Hikma

Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 …

How is COVID-19 impacting the rare disease community?

June 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …

Sanofi’s Dupixent scores Chinese approval in moderate to severe atopic dermatitis

June 22, 2020 Sales and Marketing China, Dupixent, Sanofi, atopic dermatitis, pharma

China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent …

New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market

June 22, 2020 Manufacturing and Production, Sales and Marketing COVID-19, DSRU, MEMO Research, Vaccine, coronavirus, pharma

The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together …

SAGE group warns it is not safe to relax social distancing rules across Britain

June 22, 2020 Sales and Marketing COVID-19, coronavirus, pandemic

The Independent SAGE group has warned that it is not safe to relax social distancing rules for indoor settings, after …

NIH halts hydroxychloroquine trial after no benefit found in COVID-19 patients

June 22, 2020 Sales and Marketing COVID-19, chloroquine, hydroxychloroquine, pandemic

The National Institutes of Health (NIH) have suspended clinical trials of hydroxychloroquine after the drug was found to have no …

Germany’s infection rate rapidly rises as world sees its largest daily increase in COVID-19 cases

June 22, 2020 Sales and Marketing COVID-19, coronavirus, pandemic

Germany’s coronavirus R number has drastically increased while the world faced its largest increase in cases since the pandemic began. …

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer

June 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
The Gateway to Local Adoption Series

Latest content